Clinical Trials Browser

Phase 2 × Seminoma × Docetaxel × Clear all

NCT00002903 2012-07-02

Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer

Phase 2 Completed

GenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Testicular Neoplasms, Seminoma